Abstract

Motiva Implants® (Establishment Labs Holdings Inc., NY, USA) contains a RFID micro transponder RFID(RT) (RT = registered trademark) known as Q Inside Safety Technology which provides an added safety feature embedded in the shell of the Motiva breast implant [1] [2]. Because this RFID micro transponder has Ferric components, a concern over breast MRI imaging susceptibility artifact has arisen. Among breast images, a single high risk breast cancer patient was imaged at our institution (January 2018). All breast imaging modalities were used to determine if this high risk patient had a recurrence of her cancer or any new breast cancer. The MRI showed a susceptibility artifact on the posterior margin of the implant but breast ultrasound showed no abnormalities in the area of the susceptibility artifact. By using high risk screening including Mammography, Tomosynthesis, Breast Ultrasound and Breast MRI, an adequate survey of the high risk patient was completed [3]. Our high risk clinic examined the patient and the imaging results and came to the following conclusion: This patient showed no evidence of recurrent cancer and no new masses were identified. The conclusion was BIRADS 2 benign: normal findings post-mastectomy and implants. Recommendation was for routine high risk screening at yearly interval.

Highlights

  • Motiva Implants® (Establishment Labs Holdings Inc., NY, USA) contains a RFID micro transponder RFID(RT) (RT = registered trademark) known as Q Inside Safety Technology which provides an added safety feature embedded in the shell of the Motiva breast implant [1] [2]

  • The new silicone breast implants contain a radio frequency identification device micro-transponder (RFID-M), known as the Q Inside Safety TechnologyTM, as an added safety feature embedded in the shell of its breast implant

  • The RFID causes a susceptibility artifact that is cuboidal in shape and along the posterior wall of the breast implant near the region of the chest wall

Read more

Summary

Introduction

The patient underwent bilateral mastectomy in 2010 for left breast cancer with breast implant placement and chemotherapy. In 2017, the patient has breast surgery revision with new silicone implants. The new silicone breast implants contain a radio frequency identification device micro-transponder (RFID-M), known as the Q Inside Safety TechnologyTM, as an added safety feature embedded in the shell of its breast implant. This RFID-M device allows for the rapid unique identification of implants through a three-point authentication system that contains important information about the implants manufacturing date, serial number, volume, and size [4] [5].

Conclusions
Disclosure
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call